Contribution of apelin to water balance, blood glucose control, and cardiovascular functions;Participation de l'apéline à la régulation de l'équilibre hydrique, de l'homéostasie glucidique et des fonctions cardiovasculaires

Annales d'Endocrinologie

Volumn 71, Issue 4, 2010, Pages 249-256

  Bodineau, L ^a,b   Hus Citharel, A ^a,b   Llorens Cortes, C ^a,b  

^a l'alimentation et l'Environnement   (France)

^b SORBONNE UNIVERSITÉ   (France)

Author keywords

Apelin; APJ receptor; Vasopressin

Indexed keywords

APELIN; GLUCOSE; PREPROAPELIN; PROTEIN PRECURSOR; UNCLASSIFIED DRUG;

ADIPOSE TISSUE; AMINO ACID SEQUENCE; BLOOD PRESSURE MEASUREMENT; CARDIOVASCULAR FUNCTION; DIURESIS; ELECTROLYTE BALANCE; FLUID BALANCE; GLUCOSE BLOOD LEVEL; GLUCOSE HOMEOSTASIS; GLUCOSE TRANSPORT; GLYCEMIC CONTROL; HEART CONTRACTION; HEART OUTPUT; HEART PRELOAD; INSULIN RESISTANCE; KIDNEY CIRCULATION; MICROCIRCULATION; NONHUMAN; PROTEIN FUNCTION; SHORT SURVEY; SKELETAL MUSCLE; TISSUE LEVEL; VASOPRESSIN RELEASE;

ADIPOSE TISSUE; AMINO ACID SEQUENCE; ANGIOTENSIN II; ANIMALS; BLOOD GLUCOSE; BLOOD PRESSURE; CATTLE; DIURESIS; DIURETICS; HEART; HUMANS; INSULIN RESISTANCE; INTERCELLULAR SIGNALING PEPTIDES AND PROTEINS; KIDNEY; MALE; MICE; MOLECULAR SEQUENCE DATA; MUSCLE, SKELETAL; RATS; VASOPRESSINS; WATER-ELECTROLYTE BALANCE;

EID: 77956183755     PISSN: 00034266     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ando.2010.03.004     Document Type: Short Survey

References (53)

1. O'Dowd B.F., Heiber M., Chan A., et al. A human gene that shows identity with the gene encoding the angiotensin receptor is located on chromosome 11. Gene 1993, 136:355-360.
2. Devic E., Rizzoti K., Bodin S., et al. Amino acid sequence and embryonic expression of msr/apj, the mouse homolog of Xenopus X-msr and human APJ. Mech Dev 1999, 84:199-203.
3. O'Carroll A.M., Selby T.L., Palkovits M., et al. Distribution of mRNA encoding B78/apj, the rat homologue of the human APJ receptor, and its endogenous ligand apelin in brain and peripheral tissues. Biochim Biophys Acta 2000, 1492:72-80.
4. De Mota N., Lenkei Z., Llorens-Cortes C. Cloning, pharmacological characterization and brain distribution of the rat apelin receptor. Neuroendocrinology 2000, 72:400-407.
5. Tatemoto K., Hosoya M., Habata Y., et al. Isolation and characterization of a novel endogenous peptide ligand for the human APJ receptor. Biochem Biophys Res Commun 1998, 251:471-476.
6. Lee D.K., Cheng R., Nguyen T., et al. Characterization of apelin, the ligand for the APJ receptor. J Neurochem 2000, 74:34-41.
7. Habata Y., Fujii R., Hosoya M., et al. Apelin, the natural ligand of the orphan receptor APJ, is abundantly secreted in the colostrum. Biochim Biophys Acta 1999, 1452:25-35.
8. De Mota N., Reaux-Le Goazigo A., El Messari S., et al. Apelin, a potent diuretic neuropeptide counteracting vasopressin actions through inhibition of vasopressin neuron activity and vasopressin release. Proc Natl Acad Sci U S A 2004, 101:10464-10469.
9. Kawamata Y., Habata Y., Fukusumi S., et al. Molecular properties of apelin: tissue distribution and receptor binding. Biochim Biophys Acta 2001, 1538:162-171.
10. Azizi M., Iturrioz X., Blanchard A., et al. Reciprocal regulation of plasma apelin and vasopressin by osmotic stimuli. J Am Soc Nephrol 2008, 19:1015-1024.
11. Reaux A., De Mota N., Skultetyova I., et al. Physiological role of a novel neuropeptide, apelin, and its receptor in the rat brain. J Neurochem 2001, 77:1085-1096.
12. Masri B., Lahlou H., Mazarguil H., et al. Apelin (65-77) activates extracellular signal-regulated kinases via a PTX-sensitive G protein. Biochem Biophys Res Commun 2002, 290:539-545.
13. El Messari S., Iturrioz X., Fassot C., et al. Functional dissociation of apelin receptor signaling and endocytosis: implications for the effects of apelin on arterial blood pressure. J Neurochem 2004, 90:1290-1301.
14. Zhou N., Fan X., Mukhtar M., et al. Cell-cell fusion and internalization of the CNS-based, HIV-1 co-receptor APJ. Virology 2003, 307:22-36.
15. Medhurst A.D., Jennings C.A., Robbins M.J., et al. Pharmacological and immunohistochemical characterization of the APJ receptor and its endogenous ligand apelin. J Neurochem 2003, 84:1162-1172.
16. Masri B., Morin N., Cornu M., et al. Apelin (65-77) activates p70 S6 kinase and is mitogenic for umbilical endothelial cells. Faseb J 2004, 18:1909-1911.
17. Choe W., Albright A., Sulcove J., et al. Functional expression of the seven-transmembrane HIV-1 co-receptor APJ in neural cells. J Neurovirol 2000, 6:S61-69.
18. Reaux A., Gallatz K., Palkovits M., et al. Distribution of apelin-synthesizing neurons in the adult rat brain. Neuroscience 2002, 113:653-662.
19. Brailoiu G.C., Dun S.L., Yang J., et al. Apelin-immunoreactivity in the rat hypothalamus and pituitary. Neurosci Lett 2002, 327:193-197.
20. Reaux-Le Goazigo A., Morinville A., Burlet A., et al. Dehydration-induced cross-regulation of apelin and vasopressin immunoreactivity levels in magnocellular hypothalamic neurons. Endocrinology 2004, 145:4392-4400.
21. Johnson A.K., Cunningham J.T., Thunhorst R.L. Integrative role of the lamina terminalis in the regulation of cardiovascular and body fluid homeostasis. Clin Exp Pharmacol Physiol 1996, 23:183-191.
22. O'Carroll A.M., Lolait S.J. Regulation of rat APJ receptor messenger ribonucleic acid expression in magnocellular neurones of the paraventricular and supraopric nuclei by osmotic stimuli. J Neuroendocrinol 2003, 15:661-666.
23. Hurbin A., Boissin-Agasse L., Orcel H., et al. The V1a and V1b, but not V2, vasopressin receptor genes are expressed in the supraoptic nucleus of the rat hypothalamus, and the transcripts are essentially colocalized in the vasopressinergic magnocellular neurons. Endocrinology 1998, 139:4701-4707.
24. Brownstein M.J., Russell J.T., Gainer H. Synthesis, transport, and release of posterior pituitary hormones. Science 1980, 207:373-378.
25. Manning M., Lowbridge J., Haldar J., et al. Design of neurohypophyseal peptides that exhibit selective agonistic and antagonistic properties. Fed Proc 1977, 36:1848-1852.
26. Zini S., Fournie-Zaluski M.C., Chauvel E., et al. Identification of metabolic pathways of brain angiotensin II and III using specific aminopeptidase inhibitors: predominant role of angiotensin III in the control of vasopressin release. Proc Natl Acad Sci U S A 1996, 93:11968-11973.
27. Gouzenes L., Desarmenien M.G., Hussy N., et al. Vasopressin regularizes the phasic firing pattern of rat hypothalamic magnocellular vasopressin neurons. J Neurosci 1998, 18:1879-1885.
28. Ludwig M. Dendritic release of vasopressin and oxytocin. J Neuroendocrinol 1998, 10:881-895.
29. Poulain D.A., Wakerley J.B., Dyball R.E. Electrophysiological differentiation of oxytocin- and vasopressin-secreting neurones. Proc R Soc Lond B Biol Sci 1977, 196:367-384.
30. Gimpl G., Fahrenholz F. The oxytocin receptor system: structure, function, and regulation. Physiol Rev 2001, 81:629-683.
31. Hosoya M., Kawamata Y., Fukusumi S., et al. Molecular and functional characteristics of APJ. Tissue distribution of mRNA and interaction with the endogenous ligand apelin. J Biol Chem 2000, 275:21061-21067.
32. De Falco M., De Luca L., Onori N., et al. Apelin expression in normal human tissues. In Vivo 2002, 16:333-336.
33. Hus-Citharel A., Bouby N., Frugiere A., et al. Effect of apelin on glomerular hemodynamic function in the rat kidney. Kidney Int 2008, 74:486-494.
34. Terada Y., Tomita K., Nonoguchi H., et al. Different localization and regulation of two types of vasopressin receptor messenger RNA in microdissected rat nephron segments using reverse transcription polymerase chain reaction. J Clin Invest 1993, 92:2339-2345.
35. Morello J.P., Bichet D.G. Nephrogenic diabetes insipidus. Annu Rev Physiol 2001, 63:607-630.
36. Ishida J., Hashimoto T., Hashimoto Y., et al. Regulatory roles for APJ, a seven-transmembrane receptor related to angiotensin-type 1 receptor in blood pressure in vivo. J Biol Chem 2004, 279:26274-26279.
37. Denton D.A., McKinley M.J., Weisinger R.S. Hypothalamic integration of body fluid regulation. Proc Natl Acad Sci U S A 1996, 93:7397-7404.
38. Clarke K.J., Whitaker K.W., Reyes T.M. Diminished metabolic responses to centrally-administered apelin-13 in diet-induced obese rats fed a high-fat diet. J Neuroendocrinol 2009, 21(2):83-89.
39. Taheri S., Murphy K., Cohen M., et al. The effects of centrally administered apelin-13 on food intake, water intake and pituitary hormone release in rats. Biochem Biophys Res Commun 2002, 291(5):1208-1212.
40. Sunter D., Hewson A.K., Dickson S.L. Intracerebroventricular injection of apelin-13 reduces food intake in the rat. Neurosci Lett 2003, 353(1):1-4.
41. O'Shea M., Hansen M.J., Tatemoto K., et al. Inhibitory effect of apelin-12 on nocturnal food intake in the rat. Nutr Neurosci 2003, 6(3):163-167.
42. Boucher J., Masri B., Daviaud D., et al. Apelin, a newly identified adipokine up-regulated by insulin and obesity. Endocrinology 2005, 146(4):1764-1771.
43. Dray C., Knauf C., Daviaud D., et al. Apelin stimulates glucose utilization in normal and obese insulin-resistant mice. Cell Metab 2008, 8(5):437-445.
44. Attané C., Guzman-Ruiz R., Bézaire V., et al. Un traitement chronique à l'apeline stimule l'oxydation des acides gras dans le muscle de souris normopondérales et insulinorésistantes. Diabete Metab 2009, 35(1):A15.
45. Tatemoto K., Takayama K., Zou M.X., et al. The novel peptide apelin lowers blood pressure via a nitric oxide-dependent mechanism. Regul Pept 2001, 99. [87-92Japp AG].
46. Japp A.G., Cruden N.L., Amer D.A., et al. Vascular effects of apelin in vivo in man. J Am Coll Cardiol 2008, 52:908-913.
47. Chun H.J., Ali Z.A., Kojima Y., et al. Apelin signaling antagonizes Ang II effects in mouse models of atherosclerosis. J Clin Invest 2008, 118:3343-3354.
48. Szokodi I., Tavi P., Foldes G., et al. Apelin, the novel endogenous ligand of the orphan receptor APJ, regulates cardiac contractility. Circ Res 2002, 91:434-440.
49. Chen M.M., Ashley E.A., Deng D.X., et al. Novel role for the potent endogenous inotrope apelin in human cardiac dysfunction. Circulation 2003, 108:1432-1439.
50. Berry M.F., Pirolli T.J., Jayasankar V., et al. Apelin has in vivo inotropic effects on normal and failing hearts. Circulation 2004, 110:II187-193.
51. Ashley E.A., Powers J., Chen M., et al. The endogenous peptide apelin potently improves cardiac contractility and reduces cardiac loading in vivo. Cardiovasc Res 2005, 65:73-82.
52. Foldes G., Horkay F., Szokodi I., et al. Circulating and cardiac levels of apelin, the novel ligand of the orphan receptor APJ, in patients with heart failure. Biochem Biophys Res Commun 2003, 308:480-485.
53. Kuba K., Zhang L., Imai Y., et al. Impaired heart contractility in Apelin gene-deficient mice associated with aging and pressure overload. Circ Res 2007, 101:e32-42.